Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 19
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Maternal vgll4a regulates zebrafish epiboly through Yap1 activity

  • Camacho-Macorra, Carlos
  • Tabanera, Noemí
  • Sánchez-Bustamante, Elena
  • Bovolenta, Paola
  • Cardozo, Marcos J.
Gastrulation in zebrafish embryos commences with the morphogenetic rearrangement of blastodermal cells, which undergo a coordinated spreading from the animal pole to wrap around the egg at the vegetal pole. This rearrangement, known as epiboly, relies on the orchestrated activity of maternal transcripts present in the egg, compensating for the gradual activation of the zygotic genome. Epiboly involves the mechano-transducer activity of yap1 but what are the regulators of yap1 activity and whether these are maternally or zygotically derived remain elusive. Our study reveals the crucial role of maternal vgll4a, a proposed Yap1 competitor, during zebrafish epiboly. In embryos lacking maternal/zygotic vgll4a (MZvgll4a), the progression of epiboly and blastopore closure is delayed. This delay is associated with the ruffled appearance of the sliding epithelial cells, decreased expression of yap1-downstream targets and transient impairment of the actomyosin ring at the syncytial layer. Our study also shows that, rather than competing with yap1, vgll4a modulates the levels of the E-cadherin/β-catenin adhesion complex at the blastomeres’ plasma membrane and hence their actin cortex distribution. Taking these results together, we propose that maternal vgll4a acts at epiboly initiation upstream of yap1 and the E-cadherin/β-catenin adhesion complex, contributing to a proper balance between tissue tension/cohesion and contractility, thereby promoting a timely epiboly progression., The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by grants: PID2019-104186RB-I00; RED2018-102553-T; PID2022-136831OB-I00 and RED2022-134100-T funded by MCIN/AEI/ 10.13039/501100011033 and “ERDF A way of making Europe”. CCM was supported by a predoctoral contract from the CIBERER, whereas MJC by a Juan de la Cierva postdoctoral contract (IJCI-2016-27683) funded by MCIN/AEI/10.13039/501100011033. A CBM Institutional grant from the Fundación Ramon Areces is also acknowledged. The CBM is a Center of Excellence Severo Ochoa CEX2021-001154-S funded by MCIN/AEI/10.13039/501100011033., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

ICAMs in Immunity, Intercellular Adhesion and Communication

  • Guerra-Espinosa, Claudia
  • Jiménez-Fernández, María
  • Sánchez-Madrid, Francisco
  • Serrador, Juan M.
Interactions among leukocytes and leukocytes with immune-associated auxiliary cells represent an essential feature of the immune response that requires the involvement of cell adhesion molecules (CAMs). In the immune system, CAMs include a wide range of members pertaining to different structural and functional families involved in cell development, activation, differentiation and migration. Among them, β2 integrins (LFA-1, Mac-1, p150,95 and αDβ2) are predominantly involved in homotypic and heterotypic leukocyte adhesion. β2 integrins bind to intercellular (I)CAMs, actin cytoskeleton-linked receptors belonging to immunoglobulin superfamily (IgSF)-CAMs expressed by leukocytes and vascular endothelial cells, enabling leukocyte activation and transendothelial migration. β2 integrins have long been viewed as the most important ICAMs partners, propagating intracellular signalling from β2 integrin-ICAM adhesion receptor interaction. In this review, we present previous evidence from pioneering studies and more recent findings supporting an important role for ICAMs in signal transduction. We also discuss the contribution of immune ICAMs (ICAM-1, -2, and -3) to reciprocal cell signalling and function in processes in which β2 integrins supposedly take the lead, paying particular attention to T cell activation, differentiation and migration., This study was supported by grant PID2022-140155OB-I00 to J.M.S. and grants PDC2021- 121719-I00 and PID-2020-120412RB-I00 to F.S.M. from the Spanish Ministry of Science, Innovation and Universities, and also supported by grants S2022/BMD-7209 (INTEGRAMUNE-CM) and by “La Caixa” Health Research Grant LCF/PR/HR23/52430018. C.G-E. was supported by Unión Europea—Next Generation EU. M.J-F. was supported by Formación Personal Investigador Severo Ochoa (FPI-SO) Program (PRE2019-087941), Ministry of Science, Innovation and Universities and Fondo Europeo de Desarrollo Regional (FEDER) and Fondo Social Europeo (FSE). The CBMSO receives an institutional grant from the Fundación Ramón Areces. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation. The CBMSO and the CNIC are both Severo Ochoa Center of Excellence (grant CEX2021-001154-S and grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001154-S)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001041-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pathogenic Mis-splicing of CPEB4 in Schizophrenia

  • Ollà, Ivana
  • Pardiñas, Antonio F.
  • Parras, Alberto
  • Hernández, Ivó H.
  • Santos-Galindo, María
  • Picó, Sara
  • Callado, Luis F.
  • Elorza, Ainara
  • Rodríguez-López, Claudia
  • Fernández-Miranda, Gonzalo
  • Belloc, Eulàlia
  • Walters, James T. R.
  • O'Donovan, Michael C.
  • Méndez, Raúl
  • Toma, Claudio
  • Meana, J. Javier
  • Owen, Michael J.
  • Lucas, José J.
Background: Schizophrenia (SCZ) is caused by an interplay of polygenic risk and environmental factors, which may alter regulators of gene expression leading to pathogenic misexpression of SCZ risk genes. The CPEB family of RNA-binding proteins (CPEB1–4) regulates translation of target RNAs (approximately 40% of overall genes). We previously identified CPEB4 as a key dysregulated translational regulator in autism spectrum disorder (ASD) because its neuronal-specific microexon (exon 4) is mis-spliced in ASD brains, causing underexpression of numerous ASD risk genes. The genetic factors and pathogenic mechanisms shared between SCZ and ASD led us to hypothesize CPEB4 mis-splicing in SCZ leading to underexpression of multiple SCZ-related genes. Methods: We performed MAGMA-enrichment analysis on Psychiatric Genomics Consortium genome-wide association study data and analyzed RNA sequencing data from the PsychENCODE Consortium. Reverse transcriptase polymerase chain reaction and Western blot were performed on postmortem brain tissue, and the presence/absence of antipsychotics was assessed through toxicological analysis. Finally, mice with mild overexpression of exon 4–lacking CPEB4 (CPEB4Δ4) were generated and analyzed biochemically and behaviorally. Results: First, we found enrichment of SCZ-associated genes for CPEB4-binder transcripts. We also found decreased usage of CPEB4 microexon in SCZ probands, which was correlated with decreased protein levels of CPEB4-target SCZ-associated genes only in antipsychotic-free individuals. Interestingly, differentially expressed genes fit those reported for SCZ, specifically in the SCZ probands with decreased CPEB4-microexon inclusion. Finally, we demonstrated that mice with mild overexpression of CPEB4Δ4 showed decreased protein levels of CPEB4-target SCZ genes and SCZ-linked behaviors. Conclusions: We identified aberrant CPEB4 splicing and downstream misexpression of SCZ risk genes as a novel etiological mechanism in SCZ., his work was supported by grants to JJL from: Networking Research Center on Neurodegenerative Diseases (CIBERNED) - Health Institute Carlos III (ISCIII) (Collaborative Grant No. PI2018/06-1), Spanish Ministry of Economy and Competitiveness (MINECO) (Grant No. SAF2015-65371-R), Spanish Ministry of Science, Innovation and Universities (MICIU) (Grant No. RTI2018-096322-B-I00) and Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033/FEDER,UE Grant No. PID2021-123141OB-I00); by grants to RM from MINECO (PID2020-119533GB-I00) and World Cancer Research Fund International (2020_021); by grants to CT: No. PID2020-114996RB-I00 (MCIU/AEI/FEDER,UE) and RyC2018-024106-I; and by grants to JJM and LFC from Basque Government (Grant Nos. IT-1211-19 and 1512-22). Cardiff University’s work was supported by grants to JTRW, MCO, and MJO from Medical Research Council Centre (Grant No. MR/L010305/1), Program (Grant No. MR/P005748/1), and Project (Grant Nos. MR/L011794/1, MC_PC_17212). AFP was supported by an Academy of Medical Sciences “Springboard” award (SBF005∖1083). IO was hired through European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement (Grant No. 766124). The Center for Molecular Biology Severo Ochoa is a Severo Ochoa Center of Excellence (MICIN, Award CEX2021-001154-S)., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2021-001154-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Tridimensional Structural Analysis of Tau Isoforms Generated by Intronic Retention

  • Domene-Serrano, Indalo
  • Cuadros, Raquel
  • Hernandez, Felix
  • Ávila, Jesús
  • Santa-Maria, Ismael
Tauopathies are a subset of neurodegenerative diseases characterized by abnormal tau inclusions. Recently, we have discovered a new, human specific, tau isoform termed W-tau that originates by intron 12 retention. Our preliminary data suggests this newly discovered W-tau isoform might prevent aberrant aggregation of other tau isoforms but is significantly downregulated in tauopathies such as Alzheimer's disease., This work has been supported by grants from the Spanish Ministry of Science: PID2020-113204GB-I00 (F.H.) and PID2021-123859OB-100 from MCIN /AEI/10.13039/501100011033 / FEDER, UE (J.A.). The Centro de Biología Molecular Severo Ochoa (CBMSO) is a Severo Ochoa Center of Excellence (MICIN, award CEX2021-001154-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Proteogenomic Approach to Unravel New Proteins Encoded in the Leishmania donovani (HU3) Genome

  • Adán-Jiménez, Javier
  • Sánchez-Salvador, Alejandro
  • Morato-López, Esperanza
  • Solana, José Carlos
  • Aguado, Begoña
  • Requena, José María
The high-throughput proteomics data generated by increasingly more sensible mass spectrometers greatly contribute to our better understanding of molecular and cellular mechanisms operating in live beings. Nevertheless, proteomics analyses are based on accurate genomic and protein annotations, and some information may be lost if these resources are incomplete. Here, we show that most proteomics data may be recovered by interconnecting genomics and proteomics approaches (i.e., following a proteogenomic strategy), resulting, in turn, in an improvement of gene/protein models. In this study, we generated proteomics data from Leishmania donovani (HU3 strain) promastigotes that allowed us to detect 1908 proteins in this developmental stage on the basis of the currently annotated proteins available in public databases. However, when the proteomics data were searched against all possible open reading frames existing in the L. donovani genome, twenty new protein-coding genes could be annotated. Additionally, 43 previously annotated proteins were extended at their N-terminal ends to accommodate peptides detected in the proteomics data. Also, different post-translational modifications (phosphorylation, acetylation, methylation, among others) were found to occur in a large number of Leishmania proteins. Finally, a detailed comparative analysis of the L. donovani and Leishmania major experimental proteomes served to illustrate how inaccurate conclusions can be raised if proteomes are compared solely on the basis of the listed proteins identified in each proteome. Finally, we have created data entries (based on freely available repositories) to provide and maintain updated gene/protein models. Raw data are available via ProteomeXchange with the identifier PXD051920, This research was supported by the Spanish Ministerio de Ciencia, Innovación (MICINN), Agencia Estatal de Investigación (AEI), grant number PID2020-117916RB-I00/AEI/10.13039/501100011033 and Instituto de Salud Carlos III, grant CB21/13/00018 (CIBERINFEC). The CBM receives an institutional grant from the Fundación Ramón Areces. The CBM is a Severo Ochoa Center of Excellence (grant CEX2021-001154-S), With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001154-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Glutathione overproduction mediates lymphoma initiating cells survival and has a sex-dependent effect on lymphomagenesis

  • Hernández Alcántara, Alberto
  • Kourani, Omar
  • Marcos-Jiménez, Ana
  • Martínez-Núñez, Patricia
  • Herranz-Martín, E.
  • Fuentes, Patricia
  • Toribio, María L.
  • Muñoz-Calleja, Cecilia
  • Iglesias, Teresa
  • Campanero, Miguel R.
Lymphoid tumor patients often exhibit resistance to standard therapies or experience relapse post-remission. Relapse is driven by Tumor Initiating Cells (TICs), a subset of tumor cells capable of regrowing the tumor and highly resistant to therapy. Growing cells in 3D gels is a method to discern tumorigenic cells because it strongly correlates with tumorigenicity. The finding that TICs, rather than differentiated tumor cells, grow in 3D gels offers a unique opportunity to unveil TIC-specific signaling pathways and therapeutic targets common to various cancer types. Here, we show that culturing lymphoid cells in 3D gels triggers reactive oxygen species (ROS) production, leading to non-tumor lymphoid cell death while enabling the survival and proliferation of a subset of lymphoma/leukemia cells, TICs or TIC-like cells. Treatment with the antioxidant N-acetylcysteine inhibits this lethality and promotes the growth of primary non-tumor lymphoid cells in 3D gels. A subset of lymphoma cells, characterized by an increased abundance of the antioxidant glutathione, escape ROS-induced lethality, a response not seen in non-tumor cells. Reducing glutathione production in lymphoma cells, either through pharmacological inhibition of glutamate cysteine ligase (GCL), the enzyme catalyzing the rate-limiting step in glutathione biosynthesis, or via knockdown of GCLC, the GCL catalytic subunit, sharply decreased cell growth in 3D gels and xenografts. Tumor cells from B-cell lymphoma/leukemia patients and λ-MYC mice, a B-cell lymphoma mouse model, overproduce glutathione. Importantly, pharmacological GCL inhibition hindered lymphoma growth in female λ-MYC mice, suggesting that this treatment holds promise as a therapeutic strategy for female lymphoma/leukemia patients., The CBM is supported by Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid, and is a Severo Ochoa Center of Excellence (grant CEX2021-001154-S) funded by MICIN/AEI/10.13039/501100011033. This work was supported by Fundación de la Asociación Española contra el Cáncer (AECC) grant PROYE20060CAMP to M.R.C., grant PID2022-138880OB-I00 funded by MCIN /AEI /10.13039/501100011033 / FEDER, UE to M.L.T., grant PID2020-115218RB-I00 funded by MCIN/AEI/10.13039/501100011033 to T.I., and Instituto de Salud Carlos III (CIBERNED) to T.I. O.K. held an FPI fellowship from the Spanish Ministerio de Educacion y Ciencia (BES-2014-069236)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001154-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Could there be an experimental way to link consciousness and quantum computations of brain microtubules?

  • Ávila, Jesús
  • Marco, Jesús
  • Plascencia-Villa, Germán
  • Bajic, Vladan P.
  • Perry, George
Using mathematical analyses, Penrose proposed a relation between consciousness moments and quantum computations occurring in the microtubules (MTs) of the brain. It was suggested that there is a link between brain MTs and consciousness via the entangled stage of delocalized π electrons present in the brain MTs (Hameroff and Penrose, 2014). Then, we will attempt to comment on this hypothesis step by step, looking for a possible future experimental approach that probes the hypothesis., This study was supported by a grant from the Spanish Ministry of Science (PID2021-123859OB-100/AEI/10.13039/501100011033/FEDER, UE) (JA). The Centro de Biología Molecular Severo Ochoa (CBM) is a Severo Ochoa Center of Excellence (MICIN, award CEX2021-001154-S)., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2021-001154-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Subcellular Localization Guides eNOS Function

  • Villadangos, Leticia
  • Serrador, Juan M.
Nitric oxide synthases (NOS) are enzymes responsible for the cellular production of nitric oxide (NO), a highly reactive signaling molecule involved in important physiological and pathological processes. Given its remarkable capacity to diffuse across membranes, NO cannot be stored inside cells and thus requires multiple controlling mechanisms to regulate its biological functions. In particular, the regulation of endothelial nitric oxide synthase (eNOS) activity has been shown to be crucial in vascular homeostasis, primarily affecting cardiovascular disease and other pathophysiological processes of importance for human health. Among other factors, the subcellular localization of eNOS plays an important role in regulating its enzymatic activity and the bioavailability of NO. The aim of this review is to summarize pioneering studies and more recent publications, unveiling some of the factors that influence the subcellular compartmentalization of eNOS and discussing their functional implications in health and disease., This study was supported by grant PID2022-140155OB-I00 to J.M.S. L.V. was supported by Formación de Personal Universitario Program (FPU23/00674), Ministry of Science, Innovation and Universities and Fondo Europeo de Desarrollo Regional (FEDER) and Fondo Social Europeo (FSE). CBMSO is a Severo Ochoa Center of Excellence (grant CEX2021-001154-S, funded by MICIN/AEI/10.13039/501100011033) and receives an institutional grant from Fundación Ramón Areces., With funding from the Spanish goverment through the "Severo Ochoa Centre of Excellence" accreditation (CEX2021-001154-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A general and biomedical perspective of viral quasispecies, Viral quasispecies

  • Domingo, Esteban
  • Martínez-González, Brenda
  • Somovilla, Pilar
  • García-Crespo, Carlos
  • Soria, María Eugenia
  • de Ávila, Ana Isabel
  • Gadea, Ignacio
  • Perales, Celia
Viral quasispecies refers to the complex and dynamic mutant distributions (also termed mutant spectra, clouds or swarms) that arise as a result of high error rates during RNA genome replication. The mutant spectrum of individual RNA virus populations is modified by continuous generation of variant genomes, competition and interactions among them, environmental influences, bottleneck events, and bloc transmission of viral particles. Quasispecies dynamics provides a new perspective on how viruses adapt, evolve and cause disease, and sheds light on strategies to combat them. Molecular flexibility, together with ample opportunity of mutant cloud traffic in our global world, are key ingredients of viral disease emergences, as exemplified by the recent COVID-19 pandemic. In the present article we present a brief overview of the molecular basis of mutant swarm formation and dynamics, and how the latter relates to viral disease and epidemic spread. We outline future challenges derived of the highly diverse cellular world in which viruses are necessarily installed., The work was supported by the Ministerio de Ciencia e Innovación, grants PID2020-113888RB-I00/AEI/10.13039/501100011033 and 202220I116, by the Ministerio de Ciencia, Innovación y Universidades (MICIU), grant PID2023-146622OB I00 financed by MICIU/AEI/10.13039/501100011033 and by FEDER, UE, through the “Severo Ochoa” Programmes for Centres of Excellence in R&D [CEX2021-001154-S and CEX2023-001386-S]. The work was also supported by the European Commission- Next Generation EU (regulation EU 2020/2024) through the CSIC’s Global Health Platform (PTI Salud Global). The work was also funded by grants PI21/00139 funding from Instituto de Salud Carlos III (ISCIII), co-funded by the European Union, CSIC COV19-014 from Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC) and project 525/C/2021 from Fundació La Marató de TV3, grants 202136-30 and 202136-31. We also acknowledge the project S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN), and to the Biomedicine Unit of Universidad de Castilla La Mancha (UCLM), associated with CSIC. B.M.-G. is supported by predoctoral contract PFIS FI19/00119 from Instituto de Salud Carlos III cofinanced by Fondo Social Europeo (FSE), “El FSE invierte en tu futuro”. P.S. is supported by postdoctoral contract Margarita Salas, CA1/RSUE/2021 from MCIU. C.G.-C. was supported by predoctoral contract PRE2018-083422 from MCIU, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SARS-CoV-2 biological clones are genetically heterogeneous and include clade-discordant residues

  • Ávila, Ana Isabel de
  • Soria, María Eugenia
  • Martínez-González, Brenda
  • Somovilla, Pilar
  • Mínguez, Pablo
  • Salar-Vidal, Llanos
  • Esteban-Muñoz, Mario
  • Martín-García, Marta
  • Zuñiga, Sonia
  • Solá Gurpegui, Isabel
  • Enjuanes Sánchez, Luis
  • Gadea, Ignacio
  • Perales, Celia
  • Domingo, Esteban
Defective genomes are part of SARS-CoV-2 quasispecies. High-resolution, ultra-deep sequencing of bulk RNA from viral populations does not distinguish RNA mutations, insertions, and deletions in viable genomes from those in defective genomes. To quantify SARS-CoV-2 infectious variant progeny, virus from four individual plaques (biological clones) of a preparation of isolate USA-WA1/2020, formed on Vero E6 cell monolayers, was subjected to further biological cloning to yield 9 second-generation and 15 third-generation sub-clones. Consensus genomic sequences of the biological clones and sub-clones included an average of 2.8 variations per viable genome, relative to the consensus sequence of the parental USA-WA1/2020 virus. This value is 6.5-fold lower than the estimates for biological clones of other RNA viruses such as bacteriophage Qβ, foot-and-mouth disease virus, or hepatitis C virus in cell culture. The mutant spectrum complexity of the nsp12 (polymerase)- and spike (S)-coding region was unique in the progeny of each of 10 third-generation sub-clones; they shared 2.4% of the total of 164 different mutations and deletions scored in the 3,719 genomic residues that were screened. The presence of minority out-of-frame deletions revealed the ease of defective genome production from an individual infectious genome. Several low-frequency point mutations and deletions were clade-discordant in that they were not typical of USA-WA1/2020 but served to define the consensus sequences of future SARS-CoV-2 clades. Implications for SARS-CoV-2 adaptability and COVID-19 control of the viable genome heterogeneity and the generation of complex mutant spectra from individual genomes are discussed.IMPORTANCESequencing of biological clones is a means to identify mutations, insertions, and deletions located in viable genomes. This distinction is particularly important for viral populations, such as those of SARS-CoV-2, that contain large proportions of defective genomes. By sequencing biological clones and sub-clones, we quantified the heterogeneity of the viable complement of USA-WA1/2020 to be lower than exhibited by other RNA viruses. This difference may be due to a reduced mutation rate or to limited tolerance of the large coronavirus genome to incorporate mutations and deletions and remain functional or a combination of both influences. The presence of clade-discordant residues in the progeny of individual biological sub-clones suggests limitations in the occupation of sequence space by SARS-CoV-2. However, the complex and unique mutant spectra that are rapidly generated from individual genomes suggest an aptness to confront selective constraints., The work was supported by the Ministerio de Ciencia e Innovación, grants PID2020-113888RB-I00/AEI/10.13039/501100011033 and 202220I116, by the Ministerio de Ciencia, Innovación y Universidades (MICIU), grant PID2023-146622OB-I00 financed by MICIU/AEI/10.13039/501100011033 and by FEDER, UE, through the “Severo Ochoa” Programmes for Centers of Excellence in R&D (CEX2021-001154-S and CEX2023-001386-S). The work was also supported by the European Commission Next-Generation EU (regulation EU 2020/2024) through the CSIC’s Global Health Platform (PTI Salud Global). The work was also funded by grants PI21/00139 funding from Instituto de Salud Carlos III (ISCIII), co-funded by the European Union, CSIC-COV19-014 from Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC) and project 525/C/2021 from Fundació La Marató de TV3, grants 202136-30 and 202136-31. We also acknowledge the projects TEC-607 2024/BIO-66 (SALAINDEC-CM from Comunidad de Madrid/FEDER) and S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBM belongs to the Global Virus Network (GVN) and to the Biomedicine Unit of Universidad de Castilla La Mancha (UCLM), associated with CSIC. B.M.-G. is supported by predoctoral contract PFIS FI19/00119 from Instituto de Salud Carlos III cofinanced by Fondo Social Europeo (FSE), “El FSE invierte en tu futuro.” P.S. is supported by postdoctoral contract Margarita Salas, CA1/RSUE/2021 from MCIU. P.M. is supported by the Miguel Servet program of the Instituto de Salud Carlos III (CPII21/00015), cofinanced by the European Regional Development Fund (ERDF)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A New GlyT2 Variant Associated with Hyperekplexia

  • Sarmiento-Jiménez, Jorge
  • Felipe, Raquel
  • Núñez, Enrique
  • Ferrando-Muñoz, Alejandro
  • Benito-Muñoz, Cristina
  • Gago, Federico
  • Vázquez, Jesús
  • Camafeita, Emilio
  • Clement, Emma
  • Wilson, Brian
  • López-Corcuera, Beatriz
This article belongs to the Special Issue Genetic and Genomic Diagnostics for Rare Diseases., [Data Availability Statement] The datasets generated and/or analyzed during the current study are not publicly available due to individual privacy, but some data are available from the corresponding author on reasonable request. Proteomic data are available via ProteomeXchange with the identifier PXD061845., Hyperekplexia (OMIM 149400), a sensorimotor syndrome of perinatal clinical relevance, causes newborns to display an energic startle reflex in response to certain trivial stimuli. This condition can be lethal due to apnea episodes. The disease is caused by a blockade of glycinergic neurotransmission. Glycinergic interneurons preserve their identity by the activity of the surface glycine transporter GlyT2, which supplies glycine to presynaptic terminals to maintain glycine content in synaptic vesicles. Loss-of-function mutations in the GlyT2 gene (SLC6A5) cause a presynaptic form of human hyperekplexia. Here, we describe a new GlyT2 variant found in an infantile patient diagnosed with hyperekplexia. A missense mutation in the open reading frame of the GlyT2 gene inherited in homozygosity caused the substitution G449E in a residue highly conserved across the phylogenetic scale. The sequences of the glycine receptor genes GLRA1 and GLRB did not show abnormalities. We expressed the recombinant GlyT2 variant in heterologous cells and analyzed its pathogenic mechanism. The transporter was totally inactive, behaving as a bona fide loss-of-function mutant. Furthermore, the mutation promoted the abnormal insertion of the protein into the membrane, leading to its large incorporation into lipid rafts. However, there was no apparent alteration of wild-type trafficking upon mutant coexpression, as the mutant was prematurely degraded from the endoplasmic reticulum. Rescue with chemical chaperones was not possible for this mutant. Proteomics demonstrated that the expression of the mutant induced the unfolded protein response and interfered with raft-dependent processes. Therefore, the new variant causes a loss of function regarding GlyT2 activity but a gain of function as a cell proteostasis disturber., This research was funded by the Ministerio de Ciencia e Innovación (MCIN) MCIN/AEI/10.13039/501100011033, grant numbers PID2020-119399RB-I00 and PID2023-150608OB-I00 to B.L.-C.; the Fundación Ramón Areces, grant number CIVP20A6612 to B.L.-C.; and an institutional grant from the Fundación Ramón Areces to the CBM Severo Ochoa. The work at the CNIC was supported by grant EQC2021-007053-P funded by MCIN/AEI/10.13039/501100011033 and by NextGenerationEU/PRTR; grant PID2021-122348NB-I00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”; grant PLEC2022-009298 funded by MCIN/AEI/10.13039/501100011033 and by “European Union NextGenerationEU/PRTR”; grant PLEC2022-009235 funded by MCIN/AEI/10.13039/501100011033 and by “European Union NextGenerationEU/PRTR”; grant S2022/BMD-7333-CM (INMUNOVAR-CM) funded by Comunidad de Madrid; and “la Caixa” Foundation under the project code LCF/PR/HR22/52420019 to J.V. The CBMSO is a Severo Ochoa Center of Excellence (CEX2021-001154-S). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033). Work at the University of Alcalá was supported by the MCIN grant PID2022-136307OB-C22/AEI/10.13039/501100011033., With funding form the Spanish government through the "Severa Ochoa Centre of Excellence" accreditation (CEX2021-001154-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Excessive glycosylation drives thoracic aortic aneurysm formation through integrated stress response

  • Rochano-Ortiz, Antonio
  • Simó, Carolina
  • García-Cañas, Virginia
  • Gabandé-Rodríguez, Enrique
  • Mittelbrunn, María
  • Oller, Jorge
Rochano-Ortiz et al., [Background and aims]: Thoracic aortic aneurysms and dissections (TAADs) are depicted by aortic medial degeneration characterized by glycan-rich matrix accumulation. Marfan syndrome (MFS) is the most common inherited connective tissue disorder associated with TAAD. Although vascular smooth muscle cell metabolic dysfunction has emerged as a pathogenic driver of TAAD, surgical repair remains the mainstay of treatment. This study aimed to investigate the role of the hexosamine biosynthetic pathway (HBP) in sporadic and genetic TAAD pathophysiology., [Methods]: Hexosamine biosynthetic pathway activation was analysed in aortas from an MFS mouse model, a β-aminopropionitrile-induced non-genetic TAAD model, and patients with sporadic TAAD using transcriptomic and metabolomic approaches. Aortic dilatation was monitored by ultrasound imaging. Pharmacological inhibition of HBP and integrated stress response (ISR) was performed to assess their therapeutic potential., [Results]: Hexosamine biosynthetic pathway was up-regulated in both an MFS mouse model and β-aminopropionitrile-induced TAAD, as well as in aortic samples from MFS and sporadic TAAD patients. Enhanced HBP activity contributed to aortic dilatation and medial degeneration via vascular smooth muscle cell dysfunction and ISR activation. Inhibition of HBP or ISR reversed these effects in the MFS model., [Conclusions]: The HBP-ISR axis drives medial degeneration in TAAD. These findings identify HBP and ISR as a potential target in TAAD of both genetic and non-genetic origin., A.R.-O. is supported by the Conchita-Rábago Foundation 2024 grant. J.O. is supported by a Ramón y Cajal contract (RYC2021-033343-I) and grant from Spanish Ministerio de Ciencia e Innovación grant (PID2022-137730OA-I00) funded by MCIN/AEI/10.13039/501100011033/FEDER, EU; granted by Fundación MERCK-FEDER ‘Investigación clínica en enfermedades raras 2022’, Marfan Spanish Association (SIMA, www.Marfan.es) and by ‘V-Ayudas Muévete por los que no pueden 2021’. Research in M.M.’s lab was supported by European Research Council grant ERC-2021-CoG 101044248-LetTBe and the Y2020/BIO-6350 NutriSION-CM synergy grant from Comunidad de Madrid, Ministerio de Ciencia e Innovacion, Spain (grants PID2022-141169OB-I00 and PID2022-138295OB-I00). European Research Council. M.M.-L., G.A.-L., and G.A.-E. are funded by Instituto de Salud Carlos III through the projects PI20/01103, PI23/00100, and CP22/00100 (co-funded by European Regional Development Fund/European Social Fund ‘A way to make Europe’/‘Investing in your future’). J.L.M.-V. is supported by grant from Spanish Ministerio de Ciencia e Innovación (PID2022-136979OB-I00). L.M.B.-C. is supported by Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (ISCIII/FEDER PI22/00233). G.T.-T. and A.G. are supported by Spanish Society of Cardiology (SEC/FEC-INV-CLI 20/015). O.L. is supported by grant from Spanish Health Ministry or Spanish Ministerio de Sanidad (PI20/00923 Instituto Carlos III). J.F.N. is supported by grant from Spanish Health Ministry or Spanish Ministerio de Sanidad (PI21/00084 FIS) and a grant from Health Research Institute Valdecilla (INNVAL21/24). N.M-B. is supported by Spanish Health Ministry or Spanish Ministeiro de Sanidad (PI21/01126). M.J.F.-G. is supported by Spanish Health Ministry or Spanish Ministerio de Sanidad contract (FIS22/00140). J.M.R. has received funding from La Caixa Foundation (HR18-00068); Spanish Ministerio de Ciencia e Innovación grant PID2021-122388OB-100 funded by MCIN/AEI/10.13039/501100011033; and Instituto de Salud Carlos III (CIBER-CV CB16/11/00264); Fundació La Marató TV3 grant 202334-31, and Spanish Ministerio de Ciencia e Innovación contract FPI (BES-2016-077649) to M.J.R.-R. The CBMSO is supported by Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid. CBMSO is a Severo Ochoa Centers of Excellence (grant CEX2021-001154-S) funded by MICIN/AEI/10.13039/501100011033., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2021-001154-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SARS-CoV-2 mutant spectrum complexity is an epidemiologically evolvable trait

  • Martínez-González, Brenda
  • Soria, María Eugenia
  • Ávila, Ana Isabel de
  • Somovilla, Pilar
  • Aguilar-Sabido, Claudia
  • Mínguez, Pablo
  • Ferrer-Orta, Cristina
  • Salar-Vidal, Llanos
  • Lorenzo-Redondo, Ramón
  • Delgado, Soledad
  • Morán, Federico
  • Verdaguer, Núria
  • Gadea, Ignacio
  • Domingo, Esteban
  • Perales, Celia
RNA virus populations consist of complex and dynamic mutant spectra in which most individual genomes differ in one or more positions from the other genomes of the same population. This behavior, known as quasispecies dynamics, applies to SARS-CoV-2 which exhibits intrahost genetic and functional heterogeneity while evolving at a high rate in the human population. In the present study, we describe a remarkable reduction in mutant spectrum complexity (intrahost viral genome heterogeneity) in SARS-CoV-2 isolates of late relative to early COVID-19 waves, as they reached Madrid (Spain) from 2020 until 2022. In contrast, the consensus (average) sequence of the corresponding isolates displayed a continuing divergence from the initial Wuhan-Hu-1 virus as the pandemic advanced. The mutant spectrum complexity developed upon replication in Vero E6 cells of the isolates from the first and sixth COVID-19 waves, as well as of biological clones retrieved from them, was similar. Therefore, the mutant spectrum complexity reduction observed in vivo was not due to an increased accuracy of the viral replicative machinery, but rather to other factors related to viral epidemiology or pathogenesis. Such possible factors and their implications for viral trait modifications in the course of a viral pandemic are discussed. The results establish that mutant spectrum complexity of genetically variable viruses can be an epidemiologically evolvable trait., This work was supported by the Spanish Ministry of Science and Innovation, grants PID2020-117976GB-I00, PID2020-113888RB-I00/AEI/10.13039/501100011033 and 202220I116, by the Ministerio de Ciencia, Innovación y Universidades (MICIU), grant PID2023-146622OB-I00 financed by MICIU/AEI/10.13039/501100011033, by Fondo Europeo de Desarrollo Regional (FEDER), UE, through the “Severo Ochoa” Program for Centres of Excellence in Research and Development (CEX2021-001154-S), and by the European Commission-Next Generation EU (regulation EU 2020/2024) through the Consejo Superior de Investigaciones Científicas (CSIC’s) Global Health Platform [Plataforma Temática Interdisciplinar (PTI) Salud Global]. The work was also funded by grants PI21/00139 from Instituto de Salud Carlos III, CSIC-COV19-014 from CSIC and project 525/C/2021 from Fundació La Marató de TV3, grants 202136-30 and 202136-31. We also acknowledge the projects TEC-2024/BIO-66 (SALAINDEC-CM from Comunidad de Madrid/FEDER) and S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBM are also acknowledged. The team at Centro de Biología Molecular (CBM) belongs to the Global Virus Network, and to the Biomedicine Unit of Universidad de Castilla La Mancha, associated with CSIC. B.M.-G. is supported by predoctoral contract PFIS FI19/00119 from Instituto de Salud Carlos III cofinanced by Fondo Social Europeo (FSE), “El FSE invierte en tu futuro.” P.S. is supported by postdoctoral contract Margarita Salas, CA1/RSUE/2021 from Ministerio de Ciencia, Innovación y Universidades (MICIU). P.M. is supported by the Miguel Servet program of the Instituto de Salud Carlos III (CPII21/00015), cofinanced by the European Regional Development Fund., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001154-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Special Issue “Editorial Board Members’ Collection Series: Cancer Metastasis”

  • Cabañas, Carlos
This article belongs to the Special Issue Editorial Board Members’ Collection Series: Cancer Metastasis, Cancer metastasis is the process by which neoplastic cells from a primary tumor spread to distant sites, where cancer cells establish and form new tumors, termed secondary tumors or metastases [...], Carlos Cabañas is supported by grant no. PID2021-123199OB-I00 of the Ministerio de Ciencia e Innovación (Spain) (MCIN/AEI/https://doi.org/10.13039/501100011033) and by the European Union. The CBM-SO is a “Severo Ochoa Center of Excellence” (grant no. CEX2021-001154-S) funded by MICIN/AEI/https://doi.org/10.13039/501100011033 and is also supported by an institutional grant from the Fundación Ramón Areces., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Loss of Gαq reshapes fibroblast traits and drives tumor-stroma remodeling in oral cancer progression

  • Navarro-Lérida, Inmaculada
  • Huertas-Lárez, Raquel
  • Paredes-García, Gemma
  • García-Mateos, Dafne
  • Jiménez-López, María Isabel
  • Prieto-Fernández, Llara
  • Pascual, Ania
  • Ávila-Oca, Virginia
  • López, Juan Antonio
  • Pozo, Miguel Ángel del
  • Álvarez-Teijeiro, Saúl
  • García-Pedrero, Juana María
  • García-Escudero, Ramón
  • Mayor, Federico
  • Ribas, Catalina
Head and neck squamous cell carcinoma is an aggressive malignancy with limited therapeutic options and poor outcomes. A key driver of tumor progression is the tumor microenvironment, particularly cancer-associated fibroblasts, which remodel the extracellular matrix and secrete pro-tumorigenic signals. Emerging evidence suggests that vesicle trafficking pathways regulate these secretory functions, though their role in HNSCC remains unclear. Building on our discovery of Gαq as an autophagy regulator, we investigated how its absence reshapes fibroblast behavior and modulates crosstalk with HNSCC cells. We demonstrate that loss of Gαq reprograms murine fibroblasts into a CAF-like phenotype through deregulated intracellular trafficking and increased ceramide accumulation. Gαq-deficient fibroblasts show increased collagen I deposition, ECM remodeling, and secretion. Their exosomes, enriched in tumor-promoting growth factor receptors, suppress Caveolin-1 in tumor cells and induce an EMT-like phenotype that fuels HNSCC growth. In co-culture and in vivo, Gαq-silenced fibroblasts form "railroad-track" structures guiding cancer cell migration and invasion. Reduced Gαq expression in human fibroblasts recapitulates these features, identifying Gαq as a key regulator of fibroblast plasticity and tumor-stroma interactions in HNSCC progression., We want to acknowledge the Principado de Asturias BioBank (PT23/00077), financed jointly by Servicio de Salud del Principado de Asturias, Instituto de Salud Carlos III and Fundacion Bancaria Cajastur, and integrated in the Spanish National Biobanks Network. This work was supported by Instituto de Salud Carlos III (grants PI22_00966 and PI25_01456 to CR, PI22_00167 to JMG-P, PI24_00398 to SA-T, and PI21_00208 to RG-E, co-funded with European FEDER contribution), Agencia Estatal de Investigación of Spain (grant PID2023-146735OB-I00 to FM), H2020-MSCA Program, Grant agreement 860229-ONCORNET 2.0 to FM), CIBERCV-Instituto de Salud Carlos III, Spain (grant CB16/11/00278 to FM, co-funded with European FEDER contribution), Fundación Ramón Areces grants (to FM and CR), Programa de Actividades en Biomedicina de la Comunidad de Madrid-S2022/BMD-7209-INTEGRAMUNE (to FM). CIBERONC-Instituto de Salud Carlos III (CB16/12/00390 to JMG-P, and CB16/12/00228 to RG-E, co-funded with European FEDER contribution). LP-F and RH-L are recipients of a FPU predoctoral fellowship from the Spanish Ministry of Education (FPU20/01588 and FPU22/00979, respectively), and SA-T is a recipient of a Miguel Servet research contract from ISCIII (CP23/00101) and co-funded with European FEDER contribution. AP (PEJ-2023-TL-SAL-GL-26867), and VA-O (PEJ-2024-AI-SAL-GL-33271) were supported by a European Social Fund Plus (ESF + ) co-funded grant from Comunidad Autonoma de Madrid. We also acknowledge institutional support for the CBM from Fundación Ramón Areces. The CBM is a Severo Ochoa Center of Excellence (grant CEX2021-001154-S), funded by the Spanish Agencia Estatal de Investigación. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia, Innovación Universidades (MCIU) and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIU/AEI/10.13039/501100011033)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Microfluidics-Based Ultrahigh-Throughput Screening Unveils Diverse Ketoreductases Relevant to Pharmaceutical Synthesis

  • Blas-Muñoz, Laura
  • Orrego, Alejandro H.
  • Hofmeister, Michael
  • Martínez-Salvador, John
  • Ortega, Carmen
  • Rondón Berrio, Vanessa
  • Díaz-Rullo, Jorge
  • Finnigan, James
  • Charnock, Simon
  • Fessner, Wolf-Dieter
  • González-Pastor, José Eduardo
  • Hidalgo, Aurelio
Ketoreductases (KREDs) have become increasingly valuable biocatalysts due to their ability to produce chiral alcohols with high enantioselectivity. Prior to our work, Thai et al. developed an efficient and easy assay for their discovery, but the throughput was limited. Based on their work, we developed an ultrahigh-throughput screening assay to discover KREDs. First, we optimized Thai's assay by adapting it to a droplet format and increased its throughput by combining droplet microfluidics and fluorescence-activated cell sorting (FACS). Then, we demonstrated that our new assay was reliable and sensitive by successfully screening a library of 1.5 million clones. This allowed us to discover KREDs with low identity with known enzymes or with a previously undescribed substrate scope, which could not have been predicted computationally. In conclusion, our assay was used to carry out the first metagenomic screening for KREDs in microdroplets, and it can be used to screen any large KRED library toward enzyme discovery or evolution, as well as to enable coupled ultrahigh-throughput screening assays for other enzyme activities., This work has received funding from the European Union’s Research and Innovation Framework programs Horizon 2020 and Horizon Europe under Grant Agreement numbers 635595 (“CarbaZymes”), 685474 (“MetaFluidics”), and 956631 (“CC-TOP”). The CBM is funded by “Centre of Excellence Severo Ochoa” Grant CEX2021-001154-S from MCIN/AEI/10.13039/501100011033 and receives institutional support from Fundación Ramón Areces. AHO was the recipient of a postdoctora fellowship from Comunidad de Madrid (PEJD-2018-POST/BIO-8798), L.B.-M. is the recipient of a doctoral fellowship from Comunidad de Madrid (PIPF-2022/BIO-24858), and J.D.-R. was supported by an FPI fellowship from Universidad de Alcalá (Spain) and by an FPU fellowship (FPU18/03583) from the Spanish Ministry of Universities. A generous allocation of computing time at the Scientific Computation Center of the UAM (CCC-UAM) and assistance from the Bioinformatics, Advanced Optical Microscopy, Protein Biotechnology, and Flow Cytometry core facilities at the CBM are also acknowledged. We are saddened to acknowledge the death of our coauthor J.E.G.-P. on December 17, 2024, to whom we dedicate this article. We would also like to thank Valeria Di Giacomo, Ph.D., and Allison Clark from TPM Science for providing writing support. TOC Figure created with Biorender.com., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The V-ATPase/ATG16L1 axis drives membrane remodeling during epithelial morphogenesis

  • Baonza, Gabriel
  • Alfonso-Pérez, Tatiana
  • Quintana-Quintana, Carlos
  • Herranz, Gonzalo
  • Gordillo-Vázquez, Carmen
  • El Mazjoub, Yara
  • Escudero, Luis M.
  • Míguez, David G
  • Martí, Elisa
  • Martínez-Martín, Nuria
  • Martín-Belmonte, Fernando
Epithelial tubulogenesis shapes organs by transforming unpolarized epithelial cords into hollow tubes with central lumens. Posterior neural tube formation during secondary neurulation requires tightly coordinated membrane remodeling for de novo lumen formation and resolution, yet the role of autophagy in this process remains unclear. Autophagy operates through canonical and noncanonical pathways. While canonical autophagy is primarily degradative, the V-ATPase/ATG16L1-dependent Conjugation of ATG8 to Single Membranes (CASM) regulates LC3 lipidation on endocytic compartments. Using human neural tube organoids, MDCK cysts, and epithelial tube micropatterns selectively deficient in canonical or noncanonical autophagy, we demonstrate that CASM is essential for epithelial lumen resolution. Mechanistically, the V-ATPase/ATG16L1 axis coordinates junctional remodeling, phosphoinositide transitions, and Rab-dependent endocytic and recycling pathways to ensure single-lumen formation. These findings identify noncanonical autophagy as a spatially restricted membrane-remodeling mechanism that governs epithelial morphogenesis and reveal distinct, hierarchically balanced contributions of autophagy pathways during development., This work was supported by MICINN (PID2020-120367GB-I00; PID2023-151844OB-I00; RED2022-134927-T), Fondos FEDER investigación (Horizon-MSCA-2022-DN -101119504) and Fundación Ramon Areces (CIVP18A3904). HR22-00447 from ¨La Caixa¨, RTI2018-101586-A-I00, PID2021-126298OB-100 to N.M.-M. G.H. was supported by a FPI grant from MINECO (PRE2018-085662). G.B. was supported by a FPI grant from MINECO (PRE2021-098046). C.Q.-Q. was supported by a FPI grant from MINECO (PRE2023-001612). T.A.-P. was supported by a Juan de la Cierva grant from MICINN (IJC2018-038099-I), H2020-MSCA-IF−2019-897948, and Ayuda Investigador from AECC (INVES235112ALFO). The authors acknowledge support from the Spanish Ministry of Science, Innovation and Universities through the ‘Centro de Excelencia Severo Ochoa’ award to the Centro de Biología Molecular Severo Ochoa (CBM) (Grant No. CEX2021-001154-S). This work was also supported by the Ramón Areces Foundation., With funding form the Spanish government through the "Severa Ochoa Centre of Excellence" accreditation (CEX2021-001154-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Extracellular vesicle-inspired liposomes boost immune response against pathogen antigens

  • Morales, Joaquín
  • Gutiérrez Del Burgo, Fernando
  • Benayas, Beatriz
  • Palma-Cobo, Miguel
  • Toribio, Víctor
  • Martín-Moreno, Alejandro
  • Lacruz-Pleguezuelos, Blanca
  • López-Martín, Soraya
  • Casasnovas, José María
  • Staufer, Oskar
  • Soto, Manuel
  • Yáñez-Mó, María
Developing effective vaccines against some diseases remains a global health priority. However, targeting immunity against a specific disease-related antigen requires efficient adjuvant systems that adequately promote vaccination efficacy. Extracellular vesicles have been identified as a potential adjuvant platform technology but are still limited in their reproducibility and safety. Here, we present a synthetic extracellular vesicle mimetic (EVM) platform that enhances antigen immunogenicity by incorporating the large extracellular loop (LEL) of the tetraspanin CD9, a protein abundant on natural extracellular vesicles. Liposomes with defined lipid composition were functionalized with recombinant CD9-LEL and pathogen antigens-KMP-11 from Leishmania and the SARS-CoV-2 Spike (S) protein. BALB/c mice were immunized intraperitoneally with nanovesicles carrying CD9-LEL, the pathogen antigens alone, or both. Antigen-specific IgG responses were measured by ELISA, and vesicle uptake by immune cells was assessed via flow cytometry. CD9-LEL alone did not elicit an immune response, but its co-presentation with antigens significantly enhanced specific anti-pathogen IgG titers. Notably, KMP-11 alone failed to induce detectable antibodies, while nanovesicles carrying both CD9-LEL and KMP-11 triggered strong IgG1 and IgG2b responses. Similarly, nCD9 + S induced higher IgG titers than S alone. CD9-LEL promoted uptake of nanovesicles by peritoneal macrophages, suggesting improved antigen presentation. Combining EVMs with classical adjuvants further modulated the immune profile: alum favored IgG1 (Th2 bias), while CpG ODNs enhanced IgG2a and IgG2b (Th1 bias), crucial for intracellular pathogen clearance. The platform demonstrated safety and adaptability. In conclusion, CD9-LEL-decorated EVMs represent a promising, scalable vaccine strategy capable of boosting antigen immunogenicity and directing immune polarization, offering a versatile tool for combating challenging or emergent infectious diseases., his work has been supported by grants PID2020-119627GB-I00, PDC2021-121052 and PID2023-149514OB-I00 funded by MICIU/AEI /10.13039/501100011033 and by FEDER/UE to MY-M. JM was supported by PEJ-2023-AI_SAL-GL-26725 contract and GEIVEX MOVE fellowship, BB by a graduate industrial contract IND2019_BMD-17100 and GEIVEX mobility fellowship, and MP-C by a predoctoral contract PIPF-2023/SAL-GL- 29726, all from Comunidad de Madrid; VT was supported by a FPI-UAM fellowship. JMC was Supported by the Spanish Research Council (CSIC) and Ministry of Science, Innovation and Universities (MICIU) grant PIE-RD-COVID 19 (202020E079) and by the PTI+ Salud Global and NextGeneration EU grant SGL 2103047. The Centro de Biología Molecular Severo Ochoa is the recipient of a ‘Severo Ochoa Excellence’ grant (CEX2021-001154-S) funded by MICIU/AEI/10.13039/501100011033 and receives institutional support from the Ramón Areces Foundation., Peer reviewed, Modelo experimental alternativo-NAM, Organismos alternativos no vertebrados - Microorganismos Unicelulares
e-cienciaDatos, Repositorio de Datos del Consorcio Madroño
Datos de investigación Set de datos (Dataset)

Optimizing standardized lab-grown skin substitutes reveals a proliferation-differentiation switch based in ascorbic acid

  • Molina-Oviedo, Angie Katherine
  • Sorrentino, Ilaria
  • Clares Pedrero, Irene
  • Salamanca-Gonzalez, Celina
  • Arévalo Núñez de Arenas, Eduardo
  • Mazariegos, Marina
  • CABANAS, CARLOS
  • Medraño Fernandez, Iria
The project "From 2D to 3D: Optimization of lab-grown skin substitutes reveals a physiological switch based on ascorbic acid." aimed to provide culture conditioning and adjusting of keratinocytes intended to be used in differentiation processes. The keratinocytes were evaluated on their capacity to generate competent skin constructs as a model of cellular differentiation. The influence of ascorbic acid in 2D and 3D epidermal models was characterized, as it was found to act as a physiological switch., This dataset comprises raw images obtained in the 2D and 3D analysis. The keratinocytes used correspond to HaCaT cells cultured under low calcium conditions. The results associated with FACS results should be carefully analyzed considering the differentiation trigger caused by detachment of the cells. For more information please refer to the related publications associated to this dataset.